ACT1, a synthetic peptide designed to mimic the C-terminus of the gap junction protein connexin 43 (Cx43), with high binding specificity to the tight junction associated protein zona occludens (ZO-1).
ACT1 is a synthetic peptide known for its role as a connexin43 mimetic and modulator, making it a valuable tool in the study of gap junction biology and intercellular communication. Structurally designed to mimic a specific sequence within the carboxyl terminus of connexin43 (Cx43), ACT1 enables targeted investigation into the regulation of gap junctional channels and hemichannels. Its unique biochemical properties provide researchers with a highly specific approach to dissecting the molecular mechanisms underlying connexin-mediated signaling, tissue homeostasis, and cellular responses to physiological and pathological stimuli. As such, ACT1 has gained prominence in the field of peptide research, particularly for its ability to selectively influence protein-protein interactions and downstream signaling events associated with Cx43.
Gap Junction Modulation: One of the primary applications of ACT1 lies in its use as a selective modulator of gap junction intercellular communication. By binding to the Cx43 carboxyl terminus, this peptide can disrupt or stabilize the interaction between Cx43 and its associated partners, thereby altering gap junction assembly, permeability, and turnover. Researchers utilize ACT1 to investigate the functional consequences of modulating gap junction coupling in various cell types, providing insight into the physiological regulation of electrical and metabolic signaling between adjacent cells. This application is particularly relevant in studies of cardiac, neural, and epithelial tissues where connexin43 plays a pivotal role.
Signal Transduction Studies: ACT1 serves as a powerful probe for elucidating the downstream signaling pathways that are regulated by connexin43 interactions. Its ability to interfere with the binding of regulatory proteins to the Cx43 tail allows researchers to dissect the molecular cascades involved in cellular responses such as proliferation, migration, and differentiation. By applying ACT1 in in vitro and ex vivo models, scientists can delineate the specific signaling events triggered by gap junction modulation, enhancing the understanding of connexin-dependent cellular dynamics and their relevance to tissue physiology.
Peptide-Protein Interaction Analysis: The sequence-specific nature of ACT1 makes it an ideal reagent for studying peptide-protein interactions within the context of the connexin family and their binding partners. Experimental use of ACT1 enables the identification and characterization of proteins that interact with the Cx43 carboxyl terminus, facilitating the mapping of interaction domains and the assessment of binding affinities. This approach supports the development of targeted molecular tools and contributes to the growing knowledge base regarding the structural determinants of connexin function.
Cellular Model Development: ACT1 is frequently employed in the creation of cellular models designed to investigate the consequences of altered connexin43 activity. By introducing this peptide into cultured cells or tissue explants, researchers can induce specific changes in gap junction communication and monitor the resulting phenotypic and molecular outcomes. Such models are instrumental for exploring the role of Cx43 in tissue development, stress responses, and intercellular signaling networks, thereby advancing the field of cell biology and tissue engineering.
Peptide-Based Screening Assays: The well-characterized functional properties of ACT1 support its use in high-throughput screening assays aimed at identifying modulators of gap junction activity. As a reference compound, ACT1 can help validate assay systems or serve as a positive control in screens for novel peptides, small molecules, or biologics that target connexin43 or related pathways. This application is valuable for both basic research and early-stage drug discovery efforts focused on intercellular communication and its impact on tissue function and pathology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More